Whole blood viscosity: Effect of hemodialysis treatment and implications for access patency and vascular disease

Promila Dhar, Michael Eadon, Patrick Hallak, Ramon Augustine Munoz, Mary Hammes

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Hemodialysis patients have increased mortality from cardiovascular complications. Whole blood viscosity (WBV) and red cell aggregation (RCA) may influence the pathogenesis of vascular complications in this population. The objective of this study was to determine whether the hemodialysis treatment or vascular complications were associated with impaired WBV or RCA. Methods: This prospective, cross sectional investigation included 38 patients receiving chronic hemodialysis. Blood samples for WBV, RCA and hematocrit were drawn before and after dialysis. WBV was determined between 10 and 780 s-1 and RCA was measured by calculating aggregate shape parameter. WBV and RCA were subsequently assessed for correlation with a history of vascular disease. Results: The mean WBV, aggregate shape parameter, and hematocrit post-dialysis were significantly higher than pre-dialysis values (p < 0.05). Using a linear model with WBV as the dependent variable, the covariates of aggregate shape parameter, hematocrit, weight, and history of diabetes were not significant. However, pre/post timing of the sample was a significant covariate. WBV correlated with prior access thrombosis or stenosis, especially if the patient had a history of peripheral vascular disease. Conclusions: Higher WBV correlated with an increased incidence of access failure and vascular disease. Repetitive increases in WBV and RCA with each dialysis treatment could contribute to vascular dysfunction in this patient population.

Original languageEnglish (US)
Pages (from-to)265-275
Number of pages11
JournalClinical Hemorheology and Microcirculation
Volume51
Issue number4
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Blood Viscosity
Vascular Diseases
Renal Dialysis
Cell Aggregation
Dialysis
Hematocrit
Blood Vessels
Therapeutics
Peripheral Vascular Diseases
Population
Linear Models
Pathologic Constriction
Thrombosis
Weights and Measures

Keywords

  • Access failure
  • end stage renal disease
  • hemodialysis
  • red cell aggregation
  • vascular disease
  • viscosity

ASJC Scopus subject areas

  • Hematology
  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Whole blood viscosity : Effect of hemodialysis treatment and implications for access patency and vascular disease. / Dhar, Promila; Eadon, Michael; Hallak, Patrick; Munoz, Ramon Augustine; Hammes, Mary.

In: Clinical Hemorheology and Microcirculation, Vol. 51, No. 4, 2012, p. 265-275.

Research output: Contribution to journalArticle

Dhar, Promila ; Eadon, Michael ; Hallak, Patrick ; Munoz, Ramon Augustine ; Hammes, Mary. / Whole blood viscosity : Effect of hemodialysis treatment and implications for access patency and vascular disease. In: Clinical Hemorheology and Microcirculation. 2012 ; Vol. 51, No. 4. pp. 265-275.
@article{68198d0b90e541819d07dca7787abd4e,
title = "Whole blood viscosity: Effect of hemodialysis treatment and implications for access patency and vascular disease",
abstract = "Background: Hemodialysis patients have increased mortality from cardiovascular complications. Whole blood viscosity (WBV) and red cell aggregation (RCA) may influence the pathogenesis of vascular complications in this population. The objective of this study was to determine whether the hemodialysis treatment or vascular complications were associated with impaired WBV or RCA. Methods: This prospective, cross sectional investigation included 38 patients receiving chronic hemodialysis. Blood samples for WBV, RCA and hematocrit were drawn before and after dialysis. WBV was determined between 10 and 780 s-1 and RCA was measured by calculating aggregate shape parameter. WBV and RCA were subsequently assessed for correlation with a history of vascular disease. Results: The mean WBV, aggregate shape parameter, and hematocrit post-dialysis were significantly higher than pre-dialysis values (p < 0.05). Using a linear model with WBV as the dependent variable, the covariates of aggregate shape parameter, hematocrit, weight, and history of diabetes were not significant. However, pre/post timing of the sample was a significant covariate. WBV correlated with prior access thrombosis or stenosis, especially if the patient had a history of peripheral vascular disease. Conclusions: Higher WBV correlated with an increased incidence of access failure and vascular disease. Repetitive increases in WBV and RCA with each dialysis treatment could contribute to vascular dysfunction in this patient population.",
keywords = "Access failure, end stage renal disease, hemodialysis, red cell aggregation, vascular disease, viscosity",
author = "Promila Dhar and Michael Eadon and Patrick Hallak and Munoz, {Ramon Augustine} and Mary Hammes",
year = "2012",
doi = "10.3233/CH-2012-1532",
language = "English (US)",
volume = "51",
pages = "265--275",
journal = "Clinical Hemorheology and Microcirculation",
issn = "1386-0291",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Whole blood viscosity

T2 - Effect of hemodialysis treatment and implications for access patency and vascular disease

AU - Dhar, Promila

AU - Eadon, Michael

AU - Hallak, Patrick

AU - Munoz, Ramon Augustine

AU - Hammes, Mary

PY - 2012

Y1 - 2012

N2 - Background: Hemodialysis patients have increased mortality from cardiovascular complications. Whole blood viscosity (WBV) and red cell aggregation (RCA) may influence the pathogenesis of vascular complications in this population. The objective of this study was to determine whether the hemodialysis treatment or vascular complications were associated with impaired WBV or RCA. Methods: This prospective, cross sectional investigation included 38 patients receiving chronic hemodialysis. Blood samples for WBV, RCA and hematocrit were drawn before and after dialysis. WBV was determined between 10 and 780 s-1 and RCA was measured by calculating aggregate shape parameter. WBV and RCA were subsequently assessed for correlation with a history of vascular disease. Results: The mean WBV, aggregate shape parameter, and hematocrit post-dialysis were significantly higher than pre-dialysis values (p < 0.05). Using a linear model with WBV as the dependent variable, the covariates of aggregate shape parameter, hematocrit, weight, and history of diabetes were not significant. However, pre/post timing of the sample was a significant covariate. WBV correlated with prior access thrombosis or stenosis, especially if the patient had a history of peripheral vascular disease. Conclusions: Higher WBV correlated with an increased incidence of access failure and vascular disease. Repetitive increases in WBV and RCA with each dialysis treatment could contribute to vascular dysfunction in this patient population.

AB - Background: Hemodialysis patients have increased mortality from cardiovascular complications. Whole blood viscosity (WBV) and red cell aggregation (RCA) may influence the pathogenesis of vascular complications in this population. The objective of this study was to determine whether the hemodialysis treatment or vascular complications were associated with impaired WBV or RCA. Methods: This prospective, cross sectional investigation included 38 patients receiving chronic hemodialysis. Blood samples for WBV, RCA and hematocrit were drawn before and after dialysis. WBV was determined between 10 and 780 s-1 and RCA was measured by calculating aggregate shape parameter. WBV and RCA were subsequently assessed for correlation with a history of vascular disease. Results: The mean WBV, aggregate shape parameter, and hematocrit post-dialysis were significantly higher than pre-dialysis values (p < 0.05). Using a linear model with WBV as the dependent variable, the covariates of aggregate shape parameter, hematocrit, weight, and history of diabetes were not significant. However, pre/post timing of the sample was a significant covariate. WBV correlated with prior access thrombosis or stenosis, especially if the patient had a history of peripheral vascular disease. Conclusions: Higher WBV correlated with an increased incidence of access failure and vascular disease. Repetitive increases in WBV and RCA with each dialysis treatment could contribute to vascular dysfunction in this patient population.

KW - Access failure

KW - end stage renal disease

KW - hemodialysis

KW - red cell aggregation

KW - vascular disease

KW - viscosity

UR - http://www.scopus.com/inward/record.url?scp=84865768098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865768098&partnerID=8YFLogxK

U2 - 10.3233/CH-2012-1532

DO - 10.3233/CH-2012-1532

M3 - Article

C2 - 22337820

AN - SCOPUS:84865768098

VL - 51

SP - 265

EP - 275

JO - Clinical Hemorheology and Microcirculation

JF - Clinical Hemorheology and Microcirculation

SN - 1386-0291

IS - 4

ER -